Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2024Clinical Chemistry

B-222 Receptor-donor CYP3A5 and CYP3A4 genotype testing in liver transplant patients and its influence in tacrolimus blood levels: a retrospective study

View Full Paper
Ask AI
Bookmark
Share

Authors

JPJ L Rubio PrietoHMHada C. MacherMGMiguel Ángel Gómez‐Bravo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Prieto et al. (2024) studied this question.

synapsesocial.com/papers/68e5622ee2b3180350eff419https://doi.org/10.1093/clinchem/hvae106.582
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Recipient Versus Donor <i>CYP3A4/5</i> Genotypes in Adult Liver Transplant Recipients to Achieve Therapeutic Tacrolimus Concentrations Early Post‐Transplant2025
  2. 2Pharmacogenetics Approach for Personalized Tacrolimus Dosing in Heart Transplantation: A Case Report and Literature Review2025
  3. 3Impact of donor &lt;i&gt;CYP3A5&lt;/i&gt; genotype on pharmacokinetics of tacrolimus in South African paediatric liver transplant patients2024
  4. 4Cohort Study to Determine the Impact of <i>CYP3A5</i> Genotype on Tacrolimus Dosing Requirements and Trough Concentrations in Heart Transplant Recipients2026
  5. 5Pattern of CYP3A5 and MDR-1 single nucleotide polymorphism and its impact on Tacrolimus levels and clinical outcomes in living renal allograft recipient2024